Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways
Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the rol...
Gespeichert in:
Veröffentlicht in: | Cancer research (Chicago, Ill.) Ill.), 2009-09, Vol.69 (18), p.7375-7384 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 7384 |
---|---|
container_issue | 18 |
container_start_page | 7375 |
container_title | Cancer research (Chicago, Ill.) |
container_volume | 69 |
creator | PUHR, Martin SANTER, Frédéric R NEUWIRT, Hannes SUSANI, Martin NEMETH, Jeffrey A HOBISCH, Alfred KENNER, Lukas CULIG, Zoran |
description | Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the role of SOCS-3 in prostate cancer, SOCS-3 expression was down-regulated in DU-145, LNCaP-IL-6+, and PC3 cells by consecutive SOCS-3 small interfering RNA transfections. SOCS-3 mRNA and protein expression as measured by quantitative reverse transcription-PCR and Western blot, respectively, were decreased by approximately 70% to 80% compared with controls. We observed a significant decrease in cell proliferation and viability in all SOCS-3-positive cell lines but not in the parental LNCaP cell line, which is SOCS-3 negative. In this study, we show that down-regulation of SOCS-3 leads to an increased cell death in prostate cancer cell lines. We found a considerable increase in the activation of the proapoptotic caspase-3/caspase-7, caspase-8, and caspase-9. A significant up-regulation of cleaved poly(ADP-ribose) polymerase and inhibition of Bcl-2 expression was observed in all SOCS-3-positive cell lines. Overexpression of Bcl-2 could rescue cells with decreased SOCS-3 levels from going into apoptosis. Tissue microarray data prove that SOCS-3 is highly expressed in castration-refractory tumor samples. In conclusion, we show that SOCS-3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration-resistant tumors. SOCS-3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways. |
doi_str_mv | 10.1158/0008-5472.can-09-0806 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67655466</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67655466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-e319b8ec26b9962b5e648182314ffd3a132cfb79245628cf73778a9b5d7dcae83</originalsourceid><addsrcrecordid>eNpFkc1u1DAUhS0EotPCI4C8gV2Kf2NnOUoLrVQBUmFtOY4zY8jYwXbazrvwsHXU6XR1daTvnqt7DgAfMDrHmMsvCCFZcSbIudG-Qk2FJKpfgRXmVFaCMf4arI7MCThN6U-RHCP-FpzgRlCJeLMC_y_Cva-i3cyjzi54GAZ4O09TtCmFuKh2n8Nf5y28dRuvR-c3FYWtnpNN8GcMKetsi_bGRtjacYQXVuctzNsY5s0Wrk12d0frvLXw8iFH55MzUPseXvtntZ7ClENyxbYY3Ot9egfeDHpM9v1hnoHfXy9_tVfVzY9v1-36pjJMslxZiptOWkPqrmlq0nFbM4kloZgNQ081psQMnWgI4zWRZhBUCKmbjveiN9pKegY-P_lOMfybbcpq55Ipv2hvw5xULWrOWV0XkD-Bpjyeoh3UFN1Ox73CSC21qCVytUSu2vV3hRq11FL2Ph4OzN3O9i9bhx4K8OkA6GT0OMSSp0tHjhBEEGOCPgL4LJjJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67655466</pqid></control><display><type>article</type><title>Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>PUHR, Martin ; SANTER, Frédéric R ; NEUWIRT, Hannes ; SUSANI, Martin ; NEMETH, Jeffrey A ; HOBISCH, Alfred ; KENNER, Lukas ; CULIG, Zoran</creator><creatorcontrib>PUHR, Martin ; SANTER, Frédéric R ; NEUWIRT, Hannes ; SUSANI, Martin ; NEMETH, Jeffrey A ; HOBISCH, Alfred ; KENNER, Lukas ; CULIG, Zoran</creatorcontrib><description>Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the role of SOCS-3 in prostate cancer, SOCS-3 expression was down-regulated in DU-145, LNCaP-IL-6+, and PC3 cells by consecutive SOCS-3 small interfering RNA transfections. SOCS-3 mRNA and protein expression as measured by quantitative reverse transcription-PCR and Western blot, respectively, were decreased by approximately 70% to 80% compared with controls. We observed a significant decrease in cell proliferation and viability in all SOCS-3-positive cell lines but not in the parental LNCaP cell line, which is SOCS-3 negative. In this study, we show that down-regulation of SOCS-3 leads to an increased cell death in prostate cancer cell lines. We found a considerable increase in the activation of the proapoptotic caspase-3/caspase-7, caspase-8, and caspase-9. A significant up-regulation of cleaved poly(ADP-ribose) polymerase and inhibition of Bcl-2 expression was observed in all SOCS-3-positive cell lines. Overexpression of Bcl-2 could rescue cells with decreased SOCS-3 levels from going into apoptosis. Tissue microarray data prove that SOCS-3 is highly expressed in castration-refractory tumor samples. In conclusion, we show that SOCS-3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration-resistant tumors. SOCS-3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.can-09-0806</identifier><identifier>PMID: 19738059</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Apoptosis - physiology ; Biological and medical sciences ; Caspases - metabolism ; Down-Regulation ; Enzyme Activation ; Gynecology. Andrology. Obstetrics ; Humans ; Interleukin-6 - metabolism ; Male ; Male genital diseases ; Medical sciences ; Nephrology. Urinary tract diseases ; Pharmacology. Drug treatments ; Poly(ADP-ribose) Polymerases - metabolism ; Prostatic Neoplasms - genetics ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Proto-Oncogene Proteins c-bcl-2 - biosynthesis ; Proto-Oncogene Proteins c-bcl-2 - genetics ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; RNA, Small Interfering - genetics ; Signal Transduction ; STAT1 Transcription Factor - metabolism ; STAT3 Transcription Factor - metabolism ; Suppressor of Cytokine Signaling 3 Protein ; Suppressor of Cytokine Signaling Proteins - antagonists & inhibitors ; Suppressor of Cytokine Signaling Proteins - biosynthesis ; Suppressor of Cytokine Signaling Proteins - genetics ; Suppressor of Cytokine Signaling Proteins - metabolism ; Transfection ; Tumors ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>Cancer research (Chicago, Ill.), 2009-09, Vol.69 (18), p.7375-7384</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-e319b8ec26b9962b5e648182314ffd3a132cfb79245628cf73778a9b5d7dcae83</citedby><cites>FETCH-LOGICAL-c484t-e319b8ec26b9962b5e648182314ffd3a132cfb79245628cf73778a9b5d7dcae83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,3357,27926,27927</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22020447$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19738059$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PUHR, Martin</creatorcontrib><creatorcontrib>SANTER, Frédéric R</creatorcontrib><creatorcontrib>NEUWIRT, Hannes</creatorcontrib><creatorcontrib>SUSANI, Martin</creatorcontrib><creatorcontrib>NEMETH, Jeffrey A</creatorcontrib><creatorcontrib>HOBISCH, Alfred</creatorcontrib><creatorcontrib>KENNER, Lukas</creatorcontrib><creatorcontrib>CULIG, Zoran</creatorcontrib><title>Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the role of SOCS-3 in prostate cancer, SOCS-3 expression was down-regulated in DU-145, LNCaP-IL-6+, and PC3 cells by consecutive SOCS-3 small interfering RNA transfections. SOCS-3 mRNA and protein expression as measured by quantitative reverse transcription-PCR and Western blot, respectively, were decreased by approximately 70% to 80% compared with controls. We observed a significant decrease in cell proliferation and viability in all SOCS-3-positive cell lines but not in the parental LNCaP cell line, which is SOCS-3 negative. In this study, we show that down-regulation of SOCS-3 leads to an increased cell death in prostate cancer cell lines. We found a considerable increase in the activation of the proapoptotic caspase-3/caspase-7, caspase-8, and caspase-9. A significant up-regulation of cleaved poly(ADP-ribose) polymerase and inhibition of Bcl-2 expression was observed in all SOCS-3-positive cell lines. Overexpression of Bcl-2 could rescue cells with decreased SOCS-3 levels from going into apoptosis. Tissue microarray data prove that SOCS-3 is highly expressed in castration-refractory tumor samples. In conclusion, we show that SOCS-3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration-resistant tumors. SOCS-3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways.</description><subject>Antineoplastic agents</subject><subject>Apoptosis - physiology</subject><subject>Biological and medical sciences</subject><subject>Caspases - metabolism</subject><subject>Down-Regulation</subject><subject>Enzyme Activation</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Interleukin-6 - metabolism</subject><subject>Male</subject><subject>Male genital diseases</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Prostatic Neoplasms - genetics</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - genetics</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>Signal Transduction</subject><subject>STAT1 Transcription Factor - metabolism</subject><subject>STAT3 Transcription Factor - metabolism</subject><subject>Suppressor of Cytokine Signaling 3 Protein</subject><subject>Suppressor of Cytokine Signaling Proteins - antagonists & inhibitors</subject><subject>Suppressor of Cytokine Signaling Proteins - biosynthesis</subject><subject>Suppressor of Cytokine Signaling Proteins - genetics</subject><subject>Suppressor of Cytokine Signaling Proteins - metabolism</subject><subject>Transfection</subject><subject>Tumors</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc1u1DAUhS0EotPCI4C8gV2Kf2NnOUoLrVQBUmFtOY4zY8jYwXbazrvwsHXU6XR1daTvnqt7DgAfMDrHmMsvCCFZcSbIudG-Qk2FJKpfgRXmVFaCMf4arI7MCThN6U-RHCP-FpzgRlCJeLMC_y_Cva-i3cyjzi54GAZ4O09TtCmFuKh2n8Nf5y28dRuvR-c3FYWtnpNN8GcMKetsi_bGRtjacYQXVuctzNsY5s0Wrk12d0frvLXw8iFH55MzUPseXvtntZ7ClENyxbYY3Ot9egfeDHpM9v1hnoHfXy9_tVfVzY9v1-36pjJMslxZiptOWkPqrmlq0nFbM4kloZgNQ081psQMnWgI4zWRZhBUCKmbjveiN9pKegY-P_lOMfybbcpq55Ipv2hvw5xULWrOWV0XkD-Bpjyeoh3UFN1Ox73CSC21qCVytUSu2vV3hRq11FL2Ph4OzN3O9i9bhx4K8OkA6GT0OMSSp0tHjhBEEGOCPgL4LJjJ</recordid><startdate>20090915</startdate><enddate>20090915</enddate><creator>PUHR, Martin</creator><creator>SANTER, Frédéric R</creator><creator>NEUWIRT, Hannes</creator><creator>SUSANI, Martin</creator><creator>NEMETH, Jeffrey A</creator><creator>HOBISCH, Alfred</creator><creator>KENNER, Lukas</creator><creator>CULIG, Zoran</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090915</creationdate><title>Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways</title><author>PUHR, Martin ; SANTER, Frédéric R ; NEUWIRT, Hannes ; SUSANI, Martin ; NEMETH, Jeffrey A ; HOBISCH, Alfred ; KENNER, Lukas ; CULIG, Zoran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-e319b8ec26b9962b5e648182314ffd3a132cfb79245628cf73778a9b5d7dcae83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antineoplastic agents</topic><topic>Apoptosis - physiology</topic><topic>Biological and medical sciences</topic><topic>Caspases - metabolism</topic><topic>Down-Regulation</topic><topic>Enzyme Activation</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Interleukin-6 - metabolism</topic><topic>Male</topic><topic>Male genital diseases</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Prostatic Neoplasms - genetics</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Proto-Oncogene Proteins c-bcl-2 - biosynthesis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - genetics</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>Signal Transduction</topic><topic>STAT1 Transcription Factor - metabolism</topic><topic>STAT3 Transcription Factor - metabolism</topic><topic>Suppressor of Cytokine Signaling 3 Protein</topic><topic>Suppressor of Cytokine Signaling Proteins - antagonists & inhibitors</topic><topic>Suppressor of Cytokine Signaling Proteins - biosynthesis</topic><topic>Suppressor of Cytokine Signaling Proteins - genetics</topic><topic>Suppressor of Cytokine Signaling Proteins - metabolism</topic><topic>Transfection</topic><topic>Tumors</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PUHR, Martin</creatorcontrib><creatorcontrib>SANTER, Frédéric R</creatorcontrib><creatorcontrib>NEUWIRT, Hannes</creatorcontrib><creatorcontrib>SUSANI, Martin</creatorcontrib><creatorcontrib>NEMETH, Jeffrey A</creatorcontrib><creatorcontrib>HOBISCH, Alfred</creatorcontrib><creatorcontrib>KENNER, Lukas</creatorcontrib><creatorcontrib>CULIG, Zoran</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PUHR, Martin</au><au>SANTER, Frédéric R</au><au>NEUWIRT, Hannes</au><au>SUSANI, Martin</au><au>NEMETH, Jeffrey A</au><au>HOBISCH, Alfred</au><au>KENNER, Lukas</au><au>CULIG, Zoran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2009-09-15</date><risdate>2009</risdate><volume>69</volume><issue>18</issue><spage>7375</spage><epage>7384</epage><pages>7375-7384</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Suppressor of cytokine signaling-3 (SOCS-3) acts as a negative feedback regulator of the Janus-activated kinase/signal transducers and activators of transcription factors signaling pathway and plays an important role in the development and progression of various cancers. To better understand the role of SOCS-3 in prostate cancer, SOCS-3 expression was down-regulated in DU-145, LNCaP-IL-6+, and PC3 cells by consecutive SOCS-3 small interfering RNA transfections. SOCS-3 mRNA and protein expression as measured by quantitative reverse transcription-PCR and Western blot, respectively, were decreased by approximately 70% to 80% compared with controls. We observed a significant decrease in cell proliferation and viability in all SOCS-3-positive cell lines but not in the parental LNCaP cell line, which is SOCS-3 negative. In this study, we show that down-regulation of SOCS-3 leads to an increased cell death in prostate cancer cell lines. We found a considerable increase in the activation of the proapoptotic caspase-3/caspase-7, caspase-8, and caspase-9. A significant up-regulation of cleaved poly(ADP-ribose) polymerase and inhibition of Bcl-2 expression was observed in all SOCS-3-positive cell lines. Overexpression of Bcl-2 could rescue cells with decreased SOCS-3 levels from going into apoptosis. Tissue microarray data prove that SOCS-3 is highly expressed in castration-refractory tumor samples. In conclusion, we show that SOCS-3 is an important protein in the survival machinery in prostate cancer and is overexpressed in castration-resistant tumors. SOCS-3 knockdown results in an increase of cell death via activation of the extrinsic and intrinsic apoptosis pathways.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>19738059</pmid><doi>10.1158/0008-5472.can-09-0806</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-5472 |
ispartof | Cancer research (Chicago, Ill.), 2009-09, Vol.69 (18), p.7375-7384 |
issn | 0008-5472 1538-7445 |
language | eng |
recordid | cdi_proquest_miscellaneous_67655466 |
source | MEDLINE; American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals |
subjects | Antineoplastic agents Apoptosis - physiology Biological and medical sciences Caspases - metabolism Down-Regulation Enzyme Activation Gynecology. Andrology. Obstetrics Humans Interleukin-6 - metabolism Male Male genital diseases Medical sciences Nephrology. Urinary tract diseases Pharmacology. Drug treatments Poly(ADP-ribose) Polymerases - metabolism Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Proto-Oncogene Proteins c-bcl-2 - biosynthesis Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism RNA, Small Interfering - genetics Signal Transduction STAT1 Transcription Factor - metabolism STAT3 Transcription Factor - metabolism Suppressor of Cytokine Signaling 3 Protein Suppressor of Cytokine Signaling Proteins - antagonists & inhibitors Suppressor of Cytokine Signaling Proteins - biosynthesis Suppressor of Cytokine Signaling Proteins - genetics Suppressor of Cytokine Signaling Proteins - metabolism Transfection Tumors Tumors of the urinary system Urinary tract. Prostate gland |
title | Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T01%3A23%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Down-regulation%20of%20Suppressor%20of%20Cytokine%20Signaling-3%20Causes%20Prostate%20Cancer%20Cell%20Death%20through%20Activation%20of%20the%20Extrinsic%20and%20Intrinsic%20Apoptosis%20Pathways&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=PUHR,%20Martin&rft.date=2009-09-15&rft.volume=69&rft.issue=18&rft.spage=7375&rft.epage=7384&rft.pages=7375-7384&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.can-09-0806&rft_dat=%3Cproquest_cross%3E67655466%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67655466&rft_id=info:pmid/19738059&rfr_iscdi=true |